In neuroblastoma cells (N2a) expressing mutant ataxin-3, cordycepin treatment (20 μM) reduced the levels of the protein, while it did not interfere with the levels of non-expanded ataxin-3 (both wild-type ataxin-3 human and mouse endogenous ataxin-3). Here, ATXN3 is linked to neuroblastoma.